The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women

性欲低下障碍 医学 性欲 生殖健康 生物心理社会模型 精神科 临床心理学 人类性学 人口 环境卫生 性别研究 社会学
作者
Anita H. Clayton,Irwin Goldstein,Noel N. Kim,Stanley E. Althof,Stephanie S. Faubion,Brooke Faught,Sharon J. Parish,James A. Simon,Linda Vignozzi,Kristin Christiansen,Susan R. Davis,Murray A. Freedman,Sheryl A. Kingsberg,Paraskevi‐Sofia Kirana,Lisa Larkin,Marita P. McCabe,Richard Sadovsky
出处
期刊:Mayo Clinic Proceedings [Elsevier BV]
卷期号:93 (4): 467-487 被引量:216
标识
DOI:10.1016/j.mayocp.2017.11.002
摘要

The International Society for the Study of Women's Sexual Health process of care (POC) for management of hypoactive sexual desire disorder (HSDD) algorithm was developed to provide evidence-based guidelines for diagnosis and treatment of HSDD in women by health care professionals. Affecting 10% of adult females, HSDD is associated with negative emotional and psychological states and medical conditions including depression. The algorithm was developed using a modified Delphi method to reach consensus among the 17 international panelists representing multiple disciplines. The POC starts with the health care professional asking about sexual concerns, focusing on issues related to low sexual desire/interest. Diagnosis includes distinguishing between generalized acquired HSDD and other forms of low sexual interest. Biopsychosocial assessment of potentially modifiable factors facilitates initiation of treatment with education, modification of potentially modifiable factors, and, if needed, additional therapeutic intervention: sex therapy, central nervous system agents, and hormonal therapy, guided in part by menopausal status. Sex therapy includes behavior therapy, cognitive behavior therapy, and mindfulness. The only central nervous system agent currently approved by the US Food and Drug Administration (FDA) for HSDD is flibanserin in premenopausal women; use of flibanserin in postmenopausal women with HSDD is supported by data but is not FDA approved. Hormonal therapy includes off-label use of testosterone in postmenopausal women with HSDD, which is supported by data but not FDA approved. The POC incorporates monitoring the progress of therapy. In conclusion, the International Society for the Study of Women's Sexual Health POC for the management of women with HSDD provides a rational, evidence-based guideline for health care professionals to manage patients with appropriate assessments and individualized treatments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
3秒前
XLC发布了新的文献求助10
3秒前
3秒前
4秒前
小毛发布了新的文献求助10
5秒前
6秒前
飘逸凝丝发布了新的文献求助10
7秒前
球求大佬应助可靠寒云采纳,获得10
7秒前
7秒前
7秒前
8秒前
8秒前
Zhoey完成签到,获得积分10
9秒前
9秒前
充电宝应助怡然幻梅采纳,获得10
9秒前
明眸发布了新的文献求助10
11秒前
11秒前
十一发布了新的文献求助10
12秒前
我是老大应助zhanghaoqf采纳,获得10
12秒前
镜花水月发布了新的文献求助10
14秒前
怡神001完成签到,获得积分10
14秒前
15秒前
李佳琪关注了科研通微信公众号
15秒前
15秒前
噗噗pupu酱完成签到 ,获得积分10
15秒前
ohooo完成签到,获得积分10
16秒前
16秒前
17秒前
fanjinze完成签到,获得积分10
17秒前
未来关注了科研通微信公众号
18秒前
18秒前
lagertha完成签到,获得积分10
18秒前
19秒前
希望天下0贩的0应助ohooo采纳,获得10
19秒前
19秒前
曾经念露发布了新的文献求助10
21秒前
21秒前
陈开发布了新的文献求助10
21秒前
21秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6543490
求助须知:如何正确求助?哪些是违规求助? 8333229
关于积分的说明 17857495
捐赠科研通 5650934
什么是DOI,文献DOI怎么找? 2937010
邀请新用户注册赠送积分活动 1913285
关于科研通互助平台的介绍 1775374